公开(公告)号：US12188931B2

公开(公告)日：2025-01-07

申请号：US17562055

申请日：2021-12-27

Applicant: BIO-RAD LABORATORIES, INC.

Inventor： Michelle Delanoy ,  John Flanagan ,  Audrey Arjomandi ,  Ravi Kaul ,  Steven R. Binder

IPC: C07K14/20 ,  A61K39/02 ,  G01N33/569

Abstract: The present invention relates to an immunoassay for the detection of Borrelia specific IgG, IgM and IgG/IgM antibodies in biological samples suspected of Lyme infection. The immunoassay can be performed via a standard immunoassay format or on an automated platform. In various embodiments, the immunoassay uses one or more Borrelia specific chimeric peptides VlsE-FlaB (designated pFlaB-mV), VlsE-ErpP (designated pErp59-mV), VlsE-P35 (designated pP35-mV) alone or in combination with one or more outer surface protein C (Osp C) types B or I, p58 and DbpA. Other aspects of the invention provide antigen/substrate combinations and compositions comprising combinations of the disclosed peptides and/or proteins for use in the immunoassays described herein.

公开(公告)号：US11808772B2

公开(公告)日：2023-11-07

申请号：US16632404

申请日：2018-07-19

Applicant: BIO-RAD EUROPE GMBH ,  BIO-RAD LABORATORIES, INC.

Inventor： Isabelle Batxelli-Molina ,  Florian Salipante ,  Roger P. Walker ,  John Flanagan ,  Jeannette Fareh-Michiel

IPC: G01N33/68 ,  G16B25/10

CPC classification number: G01N33/6893 ,  G01N33/6869 ,  G16B25/10 ,  G01N2333/521 ,  G01N2333/5421 ,  G01N2333/575 ,  G01N2400/40 ,  G01N2800/085

Abstract: The invention provides a method of diagnosing Non-Alcoholic Steatohepatitis (NASH) and/or the hepatic fibrosis status of a subject, especially a subject afflicted with Non-alcoholic fatty liver disease (NAFLD) or NASH, based on the level of only three or more particular biomarkers. The invention further provides a kit suitable for performing said method and the use of said method and methods of treating patients diagnosed in accordance with the disclosed methods.

公开(公告)号：US11209431B2

公开(公告)日：2021-12-28

申请号：US15766525

申请日：2016-10-06

Applicant: BIO-RAD LABORATORIES, INC.

Inventor： Michelle Delanoy ,  John Flanagan ,  Audrey Arjomandi ,  Ravi Kaul ,  Steven R. Binder

IPC: A61K39/02 ,  C07K14/10 ,  G01N33/569 ,  C07K14/20

Abstract: The present invention relates to an immunoassay for the detection of Borrelia specific IgG, IgM and IgG/IgM antibodies in biological samples suspected of Lyme infection. The immunoassay can be performed via a standard immunoassay format or on an automated platform. In various embodiments, the immunoassay uses one or more Borrelia specific chimeric peptides VlsE-FlaB (designated pFlaB-mV), VlsE-ErpP (designated pErp59-mV), VlsE-P35 (designated pP35-mV) alone or in combination with one or more outer surface protein C (Osp C) types B or I, p58 and DbpA. Other aspects of the invention provide antigen/substrate combinations and compositions comprising combinations of the disclosed peptides and/or proteins for use in the immunoassays described herein.

公开(公告)号：US20130196350A1

公开(公告)日：2013-08-01

申请号：US13755234

申请日：2013-01-31

Applicant: Bio-Rad Laboratories, Inc.

Inventor： Steven R. Binder ,  Michelle Delanoy ,  Audrey Arjomandi ,  John Flanagan

IPC: G01N33/68 ,  G01N33/74

CPC classification number: G01N33/6893 ,  G01N33/57449 ,  G01N33/6854 ,  G01N33/74

Abstract: Improved ovarian cancer assays are provided.

Abstract translation: 提供改进的卵巢癌检测。